XYL vs. NOVO-B.CO

Last updated Jun 9, 2026

XYL (Xylem Inc.) and NOVO-B.CO (Novo Nordisk A/S) are both stocks. XYL operates in Specialty Industrial Machinery (Industrials), while NOVO-B.CO operates in Biotechnology (Healthcare). Over the past 10 years, XYL returned 10.42%/yr vs 16.29%/yr for NOVO-B.CO. At a 0.13 correlation, their price movements are largely independent.

Performance

XYL vs. NOVO-B.CO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Xylem Inc. (XYL) and Novo Nordisk A/S (NOVO-B.CO). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

XYL is traded in USD, while NOVO-B.CO is traded in DKK. To make them comparable, the NOVO-B.CO values have been converted to USD using the latest available exchange rates.

Returns By Period

In the year-to-date period, XYL achieves a -18.99% return, which is significantly lower than NOVO-B.CO's -14.86% return. Over the past 10 years, XYL has underperformed NOVO-B.CO with an annualized return of 10.42%, while NOVO-B.CO has yielded a comparatively higher 16.29% annualized return.

XYL

• 1D: -0.38%
• 1M: -3.32%
• YTD: -18.99%
• 6M: -20.24%
• 1Y: -12.42%
• 3Y*: 1.17%
• 5Y*: -0.36%
• 10Y*: 10.42%

NOVO-B.CO

• 1D: 0.00%
• 1M: -8.03%
• YTD: -14.86%
• 6M: -6.49%
• 1Y: -41.18%
• 3Y*: 5.14%
• 5Y*: 18.06%
• 10Y*: 16.29%

*Multi-year figures are annualized to reflect compound growth (CAGR)

XYL vs. NOVO-B.CO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
XYL Xylem Inc.	-18.99%	18.78%	2.57%	4.77%	-6.60%	18.94%	30.90%	19.59%	-1.01%	39.50%
NOVO-B.CO Novo Nordisk A/S	-14.86%	-39.54%	-15.04%	214.95%	23.90%	65.39%	27.16%	32.88%	-10.64%	58.82%

Correlation

The correlation between XYL and NOVO-B.CO is 0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.10
Correlation (3Y) Calculated over the trailing 3-year period	0.11
Correlation (5Y) Calculated over the trailing 5-year period	0.15
Correlation (10Y) Calculated over the trailing 10-year period	0.13
Correlation (All Time) Calculated using the full available price history since Oct 13, 2011	0.13

Return for Risk

XYL vs. NOVO-B.CO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XYL

XYL Risk / Return Rank: 22
XYL Sharpe Ratio Rank: 19
XYL Sortino Ratio Rank: 18
XYL Omega Ratio Rank: 18
XYL Calmar Ratio Rank: 28
XYL Martin Ratio Rank: 23

NOVO-B.CO

NOVO-B.CO Risk / Return Rank: 13
NOVO-B.CO Sharpe Ratio Rank: 10
NOVO-B.CO Sortino Ratio Rank: 13
NOVO-B.CO Omega Ratio Rank: 12
NOVO-B.CO Calmar Ratio Rank: 12
NOVO-B.CO Martin Ratio Rank: 17

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XYL vs. NOVO-B.CO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Xylem Inc. (XYL) and Novo Nordisk A/S (NOVO-B.CO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	XYL	NOVO-B.CO	Difference
Sharpe ratio: Return per unit of total volatility	-0.51	-0.75	+0.23
Sortino ratio: Return per unit of downside risk	-0.61	-0.84	+0.24
Omega ratio: Gain probability vs. loss probability	0.92	0.88	+0.04
Calmar ratio: Return relative to maximum drawdown	-0.42	-0.76	+0.34
Martin ratio: Return relative to average drawdown	-0.95	-1.14	+0.18
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

XYL vs. NOVO-B.CO - Sharpe Ratio Comparison

The current XYL Sharpe Ratio is -0.51, which is higher than the NOVO-B.CO Sharpe Ratio of -0.75. The chart below compares the historical Sharpe Ratios of XYL and NOVO-B.CO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	XYL	NOVO-B.CO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.51	-0.75	+0.23
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.01	0.31	-0.32
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.38	0.36	+0.02
Sharpe Ratio (All Time) Calculated using the full available price history	0.47	0.66	-0.19

Drawdowns

XYL vs. NOVO-B.CO - Drawdown Comparison

The maximum XYL drawdown since its inception was -46.69%, smaller than the maximum NOVO-B.CO drawdown of -74.86%. Use the drawdown chart below to compare losses from any high point for XYL and NOVO-B.CO.

Drawdown Indicators

	XYL	NOVO-B.CO	Difference
Max Drawdown Largest peak-to-trough decline	-46.69%	-74.86%	+28.17%
Max Drawdown (1Y) Largest decline over 1 year	-30.04%	-54.88%	+24.84%
Max Drawdown (3Y) Largest decline over 3 years	-30.04%	-74.86%	+44.82%
Max Drawdown (5Y) Largest decline over 5 years	-46.69%	-74.86%	+28.17%
Max Drawdown (10Y) Largest decline over 10 years	-46.69%	-74.86%	+28.17%
Current Drawdown Current decline from peak	-27.67%	-69.56%	+41.89%
Average Drawdown Average peak-to-trough decline	-10.38%	-12.33%	+1.95%
Ulcer Index Depth and duration of drawdowns from previous peaks	13.09%	36.42%	-23.33%

Volatility

XYL vs. NOVO-B.CO - Volatility Comparison

The current volatility for Xylem Inc. (XYL) is 5.27%, while Novo Nordisk A/S (NOVO-B.CO) has a volatility of 11.16%. This indicates that XYL experiences smaller price fluctuations and is considered to be less risky than NOVO-B.CO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	XYL	NOVO-B.CO	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.27%	11.16%	-5.89%
Volatility (6M) Calculated over the trailing 6-month period	18.97%	40.40%	-21.43%
Volatility (1Y) Calculated over the trailing 1-year period	24.27%	55.90%	-31.63%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	26.03%	58.91%	-32.88%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	27.28%	45.47%	-18.19%

Dividends

XYL vs. NOVO-B.CO - Dividend Comparison

XYL's dividend yield for the trailing twelve months is around 1.52%, less than NOVO-B.CO's 4.35% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
NOVO-B.CO Novo Nordisk A/S	4.35%	3.58%	1.59%	1.01%	2.38%	2.54%	4.03%	4.22%	5.27%	4.54%	7.38%	2.50%
XYL Xylem Inc.	1.52%	1.17%	1.24%	1.15%	1.09%	0.93%	1.02%	1.22%	1.26%	1.06%	1.25%	1.54%

Financials

Frequently Asked Questions

Can I hold both XYL and NOVO-B.CO in my portfolio?

XYL and NOVO-B.CO have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.